Erschienen in:
07.05.2021 | Editorial
Imagine, believe, and achieve
verfasst von:
Amalia Peix, MD, PhD, FACC, ASNC, Kenia Padrón, MD
Erschienen in:
Journal of Nuclear Cardiology
|
Ausgabe 3/2021
Einloggen, um Zugang zu erhalten
Excerpt
Cardiac amyloidosis was an under-recognized and undertreated disease until some years ago. Multimodality imaging plays a key role in the diagnosis of this progressive infiltrative cardiomyopathy, in addition to the clinical picture, endomyocardial/fat pad biopsies, and serum cardiac biomarkers. Although echo and cardiac magnetic resonance (CMR) provide structural and functional data, but neither can provide a distinction between transthyretin amyloid cardiomyopathy (ATTR-CM) and light chain amyloid cardiomyopathy (AL-CM). …